Inhibition of eukaryotic initiation factor 4E by tomivosertib suppresses angiogenesis, growth and survival of glioblastoma and enhances chemotherapy’s efficacy
Inhibition of eukaryotic initiation factor 4E by tomivosertib suppresses angiogenesis, growth and survival of glioblastoma and enhances chemotherapy’s efficacy
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started